Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?

BACKGROUND: The existence of oestrogen receptor-negative (ER−)/progesterone receptor-positive (PR+) breast cancer continues to be an area of controversy amongst oncologists and pathologists. METHODS: To re-evaluate breast cancers originally classified as ER−/PR+ via Oncotype DX® assay and compare mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Onitilo, Adedayo A, Engel, Jessica, Joseph, Adedayo O, Li, Ya-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426004/
https://www.ncbi.nlm.nih.gov/pubmed/34567263
http://dx.doi.org/10.3332/ecancer.2021.1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426004/
https://www.ncbi.nlm.nih.gov/pubmed/34567263
http://dx.doi.org/10.3332/ecancer.2021.1278

Ejemplares similares